Building on Foundation: The Long-term Impact of Early-Stage Funding

In the case of the work led by Professor Birch-Machin's group, the initial support from the NESRF facilitated the groundwork for their seminal investigations into mitochondrial complex II's role in skin ageing and UV-induced damage. This initial investment then paved the way for subsequent studies delving deeper into mitochondrial DNA as a biomarker and even extending these investigations to marine mammals, demonstrating the far-reaching impact of foundational research. Similarly, the Fund's support for Professor Lovat's team likely provided the essential resources to explore the prognostic significance of p62 in melanoma and to investigate innovative therapeutic strategies targeting apoptosis pathways, leading to publications in high-impact journals like the Journal of Investigative Dermatology.  Furthermore, the research by Professor Reynolds' group on cyclophilin B secretion and Professor Rajan's extensive work on CYLD-defective tumors highlight how early-stage funding can empower researchers to unravel complex biological processes and identify potential therapeutic targets.  Without this initial financial impetus, these groundbreaking investigations, which have significantly advanced our understanding of skin biology, disease pathogenesis, and potential treatments, might never have come to fruition. The North Eastern Skin Research Fund's strategic provision of seed funding has therefore not only fostered a vibrant research environment within Newcastle upon Tyne but has also demonstrably contributed valuable knowledge to the global dermatological community, highlighting the critical importance of such early-stage support in nurturing scientific discovery and ultimately improving patient outcomes